News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anika Therapeutics
(NQ:
ANIK
)
28.03
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
28.03
Bid (Size)
11.22 (2)
Ask (Size)
44.84 (2)
Prev. Close
28.03
Today's Range
28.03 - 28.03
52wk Range
16.54 - 29.11
Shares Outstanding
14,828,456
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+23.70%
+23.70%
1 Month
+8.14%
+8.14%
3 Month
+8.69%
+8.69%
6 Month
+22.40%
+22.40%
1 Year
+11.81%
+11.81%
More News
Read More
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Therapeutics: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Earnings Outlook For Anika Therapeutics
March 12, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
May 29, 2024
Via
Benzinga
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
February 13, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 28, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in Upcoming Investor Conferences
November 07, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 10, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
September 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
September 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
3 Sorry Penny Stocks to Sell in August Before It’s Too Late
August 22, 2023
Via
InvestorPlace
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
August 17, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
August 14, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close